谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

Najla El Jurdi,Alex Hoover,Daniel O'Leary,Qing Cao,Ashish Gupta,Christen Ebens,Joseph E Maakaron,Brian C Betts,Armin Rashidi,Mark B Juckett,Troy Lund,Veronika Bachanova,Margaret L MacMillan,Jeffrey S Miller,Paul J Orchard,John E Wagner,Gregory Vercellotti,Daniel J Weisdorf,Kathryn Dusenbery,Stephanie Terezakis,Shernan G Holtan

Transplantation and cellular therapy（2023）

引用 1|浏览65
暂无评分
摘要
Myeloablative HCT with PTCy/Tac/MMF results in an extremely low incidence of severe acute and chronic GVHD in well-matched allotransplantation.
更多
查看译文
关键词
Myeloablative,Allogeneic,Graft-versus-host disease,Post-transplantation cyclophosphamide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要